Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patent litigation
Pharma
Regeneron, Celltrion shake hands on Eylea biosimilar settlement
With the settlement, Celltrion can launch its recently approved Eylea biosimilar Eydenzelt on Dec. 31, 2026.
Zoey Becker
Oct 22, 2025 8:15am
AbbVie, BeOne end BTK inhibitor patent fight
Oct 2, 2025 10:29am
AbbVie settles lawsuit to ward off Rinvoq generics until 2037
Sep 11, 2025 1:36pm
Settlement allows Sandoz to launch Eylea biosimilar in late 2026
Sep 9, 2025 10:30am
GSK adds Moderna's next-gen COVID shot to mRNA patent lawsuit
Sep 5, 2025 10:06am
Amgen gets some relief in Blincyto patent feud with Lindis
Aug 15, 2025 10:13am
